Reuters Health: Weight-loss surgery tied to lowered risk of colorectal cancer
Finding supports what UC researcher has been saying about bariatric surgery
Obese people who have weight-loss surgery may also lower their risk of developing colorectal cancer, according to a report from Reuters Health. Obesity has long been linked to increased risk of colorectal tumors and other types of cancer, as well as a greater risk for chronic illnesses like diabetes and heart disease. Losing weight is thought to reduce these risks.
Reuters Health cited a study from Kuwaiti researcher, Dr. Sulaiman Almazeedi, and interviewed Dr. Daniel Schauer, an assistant professor in the University of Cincinnati Department of Internal Medicine, for a story. Schauer, also a UC Health physician, did not take part in the study, but offered his comments.
The study examined data from seven previous studies that followed more than 1.2 million patients for about seven years, on average. Colorectal cancer was rare: just 638 people developed these tumors during the study.
When people lose weight after bariatric surgery, many changes happen that impact cancer risk, explained Schauer, who was not part of the study.
“Perhaps most importantly for colorectal cancer risk, the body has less inflammation and many of the (tumor) growth factors associated with obesity are decreased,” Schauer told Reuters Health. “These are strongly related to the amount of weight loss.”
Read the Reuters Health story online.
Also check out Dr. Schauer’s research on bariatric surgery and colorectal cancer.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.
Celebrating the newest Bearcats on Decision Day
December 11, 2025
The University of Cincinnati admits its newest Bearcats for Fall 2026. Interest in the university is at an all-time high with more than 35,000 applicants for admission. Decision Day was also a time to celebrate 10 new Marian Spencer Scholarship recipients.